Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore common zero based budgeting pitfalls and practical remedies to keep your plan on course and your finances steady.
28,655 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Friday's session put cybersecurity stocks in retreat as investors priced in AI-driven commoditization risks. Palo Alt...
Meta's internal AI model is circulating a long-range Bitcoin forecast for end-2026, highlighting supply constraints, ...
A lithium-tech company unveils a faster, higher-yield extraction method and is moving into commercial-scale productio...
XRP holds firm while BTC and ETH slide, buoyed by steady ETF flows into XRP products and a surge in XRP wallet activi...
Amazon is edging toward a $3 trillion market cap as cloud growth and aggressive capital spending power a potential mi...
Broadcom posted a solid quarter but guided toward softer AI chip sales, sending its stock lower and dragging peers li...
Oracle’s stock is enduring its worst stretch in a generation as the AI debate intensifies, cloud growth battles margi...
NVIDIA CEO Jensen Huang challenges the AI jobs doomsayers narrative as the company posts blockbuster revenue driven b...
Idaho's dairy industry, valued at about $20 billion, is grappling with labor shortages driven by tightened immigratio...
Three major covered-call ETFs compete for monthly income and equity exposure, but their upside and risk profiles dive...
Markets react to health headlines and policy shifts as investors reassess exposure to healthcare, insurance, and biot...